Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®

Clinical trial NCT00731081 · COMPLETED

Trial details

NCT number: NCT00731081
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Pompe Disease (Late-Onset)Glycogen Storage Disease Type II (GSD II)Glycogenesis 2 Acid Maltase Deficiency

Start date: 2007-03-01
Primary completion: 2009-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.